FGF signaling in the developing endochondral skeleton

Cytokine and Growth Factor Reviews

Volumn 16, Issue 2 SPEC. ISS., 2005, Pages 205-213

  Ornitz, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Achondroplasia; Craniosynostosis; FGF; Receptor tyrosine kinase; Skeletal development

Indexed keywords

BCL 12 PROTEIN; COLLAGEN TYPE 2; COLLAGENASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1; FIBROBLAST GROWTH FACTOR 17; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; KERATINOCYTE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN KINASE B; PROTEIN P16; PROTEIN P18; PROTEIN P19; SOMATOMEDIN C; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ACROCEPHALOSYNDACTYLY; ANGIOGENESIS; BONE DEVELOPMENT; BONE DISEASE; BONE GROWTH; CARTILAGE CELL; CHONDROGENESIS; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; DWARFISM; ENCHONDRAL OSSIFICATION; ENZYME PHOSPHORYLATION; GENE MUTATION; GENETIC DISORDER; GROWTH PLATE; HUMAN; JACKSON WEISS SYNDROME; KALLMANN SYNDROME; MUENKE SYNDROME; OSTEOBLAST; PATHOPHYSIOLOGY; PERICHONDRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; THANATOPHORIC DWARFISM; TRANSGENIC MOUSE;

EID: 18144391965     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.02.003     Document Type: Short Survey

References (128)

1. W.A. Horton, and G.P. Lunstrum Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism Rev Endocr Metab Disord 3 2002 381 385
2. S. Ikegawa, Y. Fukushima, M. Isomura, F. Takada, and Y. Nakamura Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients Hum Genet 96 1995 309 311
3. F. Rousseau, J. Bonaventure, L. Legeal-Mallet, A. Pelet, J.-M. Rozet, and P. Maroteaux Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia Nature 371 1994 252 254
4. R. Shiang, L.M. Thompson, Y.-Z. Zhu, D.M. Church, T.J. Fielder, and M. Bocian Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia Cell 78 1994 335 342
5. A. Superti-Furga, G. Eich, H.U. Bucher, J. Wisser, A. Giedion, and R. Gitzelmann A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia Eur J Pediatr 154 1995 215 219
6. G.A. Bellus, I. Mclntosh, E.A. Smith, A.S. Aylesworth, I. Kaitila, and W.A. Horton A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia Nat Genet 10 1995 357 359
7. A. Winterpacht, K. Hilbert, C. Stelzer, T. Schweikardt, H. Decker, and H. Segerer A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia Physiol Genom 2 2000 9 12
8. F. Rousseau, V. el Ghouzzi, A.L. Delezoide, L. Legeai-Mallet, M. Le Merrer, and A. Munnich Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1) Hum Mol Genet 5 1996 509 512
9. P.L. Tavormina, D.L. Rimoin, D.H. Cohn, Y.Z. Zhu, R. Shiang, and J.J. Wasmuth Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I Hum Mol Genet 4 1995 2175 2177
10. P.L. Tavormina, R. Shiang, L.M. Thompson, Y. Zhu, D.J. Wilkin, and R.S. Lachman Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 Nat Genet 9 1995 321 328
11. J.A. Britto, R.D. Evans, R.D. Hayward, and B.M. Jones From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes Plast Reconstr Surg 108 2001 2026 2039 (discussion 2040-2026)
12. M.M.J. Cohen Fibroblast growth factor receptor mutations M.M.J. Cohen R.E. MacLean Craniosynostosis, diagnosis, evaluation and management 2000 Oxford University Press New York 77 94
13. M. Muenke, and U. Schell Fibroblast-growth-factor receptor mutations in human skeletal disorders Trends Genet 11 1995 308 313
14. M.C. Naski, and D.M. Ornitz FGF signaling in skeletal development Front Biosci 3 1998 D781 D794
15. D.M. Ornitz Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3 Novartis Found Symp 232 2001 63 76 discussion 76-80, 272-282
16. D.M. Ornitz, and P.J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes Develop 16 2002 1446 1465
17. A.O.M. Wilkie Craniosynostosis - genes and mechanisms Hum Mol Genet 6 1997 1647 1656
18. A.O.M. Wilkie, S.F. Slaney, M. Oldridge, M.D. Poole, G.J. Ashworth, and A.D. Hockley Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome Nat Genet 9 1995 165 172
19. K.A. Przylepa, W. Paznekas, M. Zhang, M. Golabi, W. Bias, and M.J. Bamshad Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome Nat Genet 13 1996 492 494
20. T.J. de Ravel, I.B. Taylor, A.J. Van Oostveldt, J.P. Fryns, and A.O. Wilkie A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome Eur J Hum Genet 2004
21. M.C. Gorry, R.A. Preston, G.J. White, Y. Zhang, V.K. Singhal, and H.W. Losken Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome Hum Mol Genet 4 1995 1387 1390
22. E.W. Jabs, X. Li, A.F. Scott, G. Meyers, W. Chen, and M. Eccles Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2 Nat Genet 8 1994 275 279
23. G.A. Meyers, D. Day, R. Goldberg, D.L. Daentl, K.A. Przylepa, and L.J. Abrams FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing Am J Hum Genet 58 1996 491 498
24. G.A. Meyers, S.J. Orlow, I.R. Munro, K.A. Przylepa, and E.W. Jabs Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans Nat Genet 11 1995 462 464
25. M. Oldridge, A.O. Wilkie, S.F. Slaney, M.D. Poole, L.J. Pulleyn, and P. Rutland Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome Hum Mol Genet 4 1995 1077 1082
26. W.J. Park, G.A. Meyers, X. Li, C. Theda, D. Day, and S.J. Orlow Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability Hum Mol Genet 4 1995 1229 1233
27. W. Reardon, R.M. Winter, P. Rutland, L.J. Pulleyn, B.M. Jones, and S. Malcolm Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome Nat Genet 8 1994 98 103
28. P. Rutland, L.J. Pulleyn, W. Reardon, M. Baraitser, R. Hayward, and B. Jones Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes Nat Genet 9 1995 173 176
29. U. Schell, A. Hehr, G.J. Feldman, N.H. Robin, E.H. Zackai, and C. de Die-Smulders Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome Hum Mol Genet 4 1995 323 328
30. D. Steinberger, J.B. Mulliken, and U. Muller Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome Hum Genet 96 1995 113 115
31. D. Steinberger, J.B. Mulliken, and U. Muller Crouzon syndrome: previously unrecognized deletion, duplication, and point mutation within FGFR2 gene Hum Mutat 8 1996 386 390
32. A.O.M. Wilkie, G.M. Morriss-Kay, E.Y. Jones, and J.K. Heath Functions of fibroblast growth factors and their receptors Curr Biol 5 1995 500 507
33. M.C. Addor, F. Gudinchet, R.N. Laurini, G. Pescia, and D.F. Schorderet A new case of Pfeiffer syndrome with mutation in FGFR2 Genet Counsel 8 1997 303 309
34. L.R. Cornejo-Roldan, E. Roessler, and M. Muenke Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome Hum Genet 104 1999 425 431
35. K.W. Gripp, C.A. Stolle, D.M. McDonald-McGinn, R.I. Markowitz, S.P. Bartlett, and J.A. Katowitz Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III Am J Med Genet 78 1998 356 360
36. E. Lajeunie, H.W. Ma, J. Bonaventure, A. Munnich, and M. LeMerrer FGFR2 mutations in Pfeiffer syndrome Nat Genet 9 1995 108
37. I.M.J. Mathijssen, J.M. Vaandrager, A.J.M. Hoogeboom, A.L.W. Hesselingjanssen, and A.M.W. Vandenouweland Pfeiffers-syndrome resulting from an S351c mutation in the fibroblast growth factor receptor-2 gene J. Craniofacial Surgery 9 1998 207 209
38. G.A. Bellus, K. Gaudenz, E.H. Zackai, L.A. Clarke, J. Szabo, and C.A. Francomano Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes Nat Genet 14 1996 174 176
39. A.O. Wilkie, S.J. Patey, S.H. Kan, A.M. van den Ouweland, and B.C. Hamel FGFs, their receptors, and human limb malformations: clinical and molecular correlations Am J Med Genet 112 2002 266 278
40. O.A. Ibrahimi, F. Zhang, A.V. Eliseenkova, R.J. Linhardt, and M. Mohammadi Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity Hum Mol Genet 13 2004 69 78
41. M. Muenke, U. Schell, A. Hehr, N.H. Robin, H.W. Losken, and A. Schinzel A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome Nat Genet 8 1994 269 274
42. M. Rossi, R.L. Jones, G. Norbury, A. Bloch-Zupan, and R.M. Winter The appearance of the feet in Pfeiffer syndrome caused by FGFR1 P252R mutation Clin Dysmorphol 12 2003 269 274
43. K.E. White, J.M. Cabral, S.I. Davis, T. Fishburn, W.E. Evans, and S. Ichikawa Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation Am J Hum Genet 2004 76
44. T. Roscioli, S. Flanagan, P. Kumar, J. Masel, M. Gattas, and V.J. Hyland Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature Am J Med Genet 93 2000 22 28
45. C. Dode, J. Levilliers, J.M. Dupont, A. De Paepe, N. Le Du, and N. Soussi-Yanicostas Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome Nat Genet 33 2003 463 465
46. M. Muenke, K.W. Gripp, D.M. McDonald-McGinn, K. Gaudenz, L.A. Whitaker, and S.P. Bartlett A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome Am J Hum Genet 60 1997 555 564
47. G. Sabatino, F. Di Rocco, G. Zampino, G. Tamburrini, M. Caldarelli, and C. Di Rocco Muenke syndrome ChildsNerv Syst 20 2004 297 301
48. G.A. Bellus, M.J. Bamshad, K.A. Przylepa, J. Dorst, R.R. Lee, and O. Hurko Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3 Am J Med Genet 85 1999 53 65
49. M.M. Cohen Jr. Let's call it "Crouzonodermoskeletal syndrome" so we won't be prisoners of our own conventional terminology Am J Med Genet 84 1999 74
50. A. Jeftha, L. Stephen, J.A. Morkel, and P. Beighton Crouzonodermoskeletal syndrome J Clin Pediatr Dent 28 2004 173 176
51. T. Nagase, M. Nagase, S. Hirose, and K. Ohmori Crouzon syndrome with acanthosis nigricans: case report and mutational analysis Cleft Palate-Craniofacial J 37 2000 78 82
52. D. Wilkes, P. Rutland, L.J. Pulleyn, W. Reardon, C. Moss, and J.P. Ellis A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans J Med Genet 33 1996 744 748
53. R.A. Kosher, W.M. Kulyk, and S.W. Gay Collagen gene expression during limb cartilage differentiation J Cell Biol 102 1986 1151 1156
54. H.D. Nah, B.J. Rodgers, W.M. Kulyk, B.E. Kream, R.A. Kosher, and W.B. Upholt In situ hybridization analysis of the expression of the type II collagen gene in the developing chicken limb bud Coll Relat Res 8 1988 277 294
55. L. Shum, C.M. Coleman, Y. Hatakeyama, and R.S. Tuan Morphogenesis and dysmorphogenesis of the appendicular skeleton Birth Defects Res Part C, Embryo Today: Rev 69 2003 102 122
56. E. Wright, M.R. Hargrave, J. Christiansen, L. Cooper, J. Kun, and T. Evans The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos Nat Genet 9 1995 15 20
57. B.K. Hall, and T. Miyake The membranous skeleton: the role of cell condensations invertebrate skeletogenesis AnatEmbryol (Berl) 186 1992 107 124
58. B.K. Hall, and T. Miyake All for one and one for all: condensations and the initiation of skeletal development Bioessays 22 2000 138 147
59. T.M. Schmid, and T.F. Linsenmayer Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues J Cell Biol 100 1985 598 605
60. K.J. Noonan, E.B. Hunziker, J. Nessler, and J.A. Buckwalter Changes in cell, matrix compartment, and fibrillar collagen volumes between growth-plate zones J Orthop Res 16 1998 500 508
61. A.I. Caplan, and D.G. Pechak The cellular and molecular embryology of bone formation W.A. Peck Bone and mineral research 1987 Elsevier New York 117 183
62. G. Karsenty, and E.F. Wagner Reaching a genetic and molecular understanding of skeletal development Develop Cell 2 2002 389 406
63. H.M. Kronenberg Developmental regulation of the growth plate Nature 423 2003 332 336
64. B.R. Olsen, A.M. Reginato, and W. Wang Bone development Annu Rev Cell Dev Biol 16 2000 191 220
65. E.F. Wagner, and G. Karsenty Genetic control of skeletal development Curr Opin Genet Dev 11 2001 527 532
66. K.G. Peters, S. Werner, G. Chen, and L.T. Williams Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse Development 114 1992 233 243
67. A.L. Delezoide, C. Benoistlasselin, L. Legeaimallet, M. Lemerrer, A. Munnich, and M. Vekemans Spatio-temporal expression of Fgfr 1, 2 and 3 genes during human embryo-fetal ossification Mech Dev 77 1998 19 30
68. A. Orr-Urtreger, D. Givol, A. Yayon, Y. Yarden, and P. Lonai Developmental expression of two murine fibroblast growth factor receptors, flg and bek Development 773 1991 1419 1434
69. G. Szebenyi, M.P. Savage, B.B. Olwin, and J.F. Fallon Changes in the expression of fibroblast growth factor receptors mark distinct stages of chondrogenesis in vitro and during chick limb skeletal patterning Dev Dyn 204 1995 446 456
70. J.S. Colvin, B. Feldman, J.H. Nadeau, M. Goldfarb, and D.M. Ornitz Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene Dev Dyn 216 1999 72 88
71. O. deLapeyriere, V. Ollendorff, J. Planche, M.O. Ott, S. Pizette, and F. Coulier Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo Development 118 1993 601 611
72. P.W. Finch, G.R. Cunha, J.S. Rubin, J. Wong, and D. Ron Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions Dev Dyn 203 1995 223 240
73. O. Haub, and M. Goldfarb Expression of the fibroblast growth factor-5 gene in the mouse embryo Development 112 1991 397 406
74. I.J. Mason, F. Fuller-Pace, R. Smith, and C. Dickson FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions Mech Dev 45 1994 15 30
75. M.P. Savage, and J.F. Fallon FGF-2 mRNA and its antisense message are expressed in a developmentally specific manner in the chick limb bud and mesonephros Dev Dyn 202 1995 343 353
76. F. Fiore, J. Planche, P. Gibier, A. Sebille, O. Delapeyriere, and D. Birnbaum Apparent normal phenotype of Fgf6-/- mice Int J Devel Biol 41 1997 639 642
77. L. Guo, L. Degenstein, and E. Fuchs Keratinocyte growth factor is required for hair development but not for wound healing Genes Dev 10 1996 165 175
78. J.M. Hebert, T. Rosenquist, J. Gotz, and G.R. Martin FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations Cell 78 1994 1017 1025
79. S. Murakami, M. Kan, W.L. McKeehan, and B. de Crombrugghe Proc Natl Acad Sci USA Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway 97 2000 1113 1118
80. T. Iwata, L. Chen, C. Li, D.A. Ovchinnikov, R.R. Behringer, and C.A. Francomano A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos Hum Mol Genet 9 2000 1603 1613
81. T. Iwata, C.L. Li, C.X. Deng, and C.A. Francomano Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice Hum Mol Genet 10 2001 1255 1264
82. N.B. Weksler, G.P. Lunstrum, E.S. Reid, and W.A. Horton Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro Biochem J 342 1999 677 682
83. K. Yu, A.B. Herr, G. Waksman, and D.M. Ornitz Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome Proc Natl Acad Sci USA 97 2000 14536 14541
84. K. Yu, and D.M. Ornitz Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes Proc Natl Acad Sci USA 98 2001 3641 3643
85. O.A. Ibrahimi, F. Zhang, A.V. Eliseenkova, N. Itoh, R.J. Linhardt, and M. Mohammadi Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities Hum Mol Genet 13 2004 2313 2324
86. L. Xiao, T. Naganawa, E. Obugunde, G. Gronowicz, D.M. Ornitz, and J.D. Coffin Statl controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts J Biol Chem 279 2004 21143 21152
87. C. Deng, A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder Fibroblast growth factor receptor 3 is a negative regulator of bone growth Cell 84 1996 911 921
88. K. Peters, D.M. Ornitz, S. Werner, and L. Williams Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis Dev Biol 155 1993 423 430
89. M.C. Naski, J.S. Colvin, J.D. Coffin, and D.M. Ornitz Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3 Development 125 1998 4977 4988
90. S.G. Pandit, P. Govindraj, J. Sasse, P.J. Neame, and J.R. Hassell The fibroblast growth factor receptor, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs Biochem J 361 2002 231 241
91. R. Sullivan, and M. Klagsbrun Purification of cartilage-derived growth factor by heparin affinity chromatography J Biol Chem 260 1985 2399 2403
92. M.M. Hurley, C. Abreu, G. Gronowicz, H. Kawaguchi, and J. Lorenzo Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells J Biol Chem 269 1994 9392 9396
93. M.M. Hurley, S. Tetradis, Y.F. Huang, J. Hock, B.E. Kream, and L.G. Raisz Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells J Bone Miner Res 14 1999 776 783
94. A. Montero, Y. Okada, M. Tomita, M. Ito, H. Tsurukami, and T. Nakamura Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation J Clin Invest 105 2000 1085 1093
95. M.G. Sabbieti, L. Marchetti, C. Abreu, A. Montero, A.R. Hand, and L.G. Raisz Prostaglandins regulate the expression of fibroblast growth factor-2 in bone Endocrinology 140 1999 434 444
96. Y. Okada, A. Montero, X. Zhang, T. Sobue, J. Lorenzo, and T. Doetschman Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone J Biol Chem 2003
97. S. Garofalo, M. Kliger-Spatz, J.L. Cooke, O. Wolstin, G.P. Lunstrum, and S.M. Moshkovitz Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice J Bone Miner Res 14 1999 1909 1915
98. Z. Liu, J. Xu, J.S. Colvin, and D.M. Ornitz Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18 Genes Develop 16 2002 859 869
99. N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi, T. Fujimori, and N. Itoh FGF 18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis Genes Develop 16 2002 870 879
100. J. Xu, A. Lawshe, C.A. Mac Arthur, and D.M. Ornitz Genomic structure, mapping, activity and expression of fibroblast growth factor 17 Mech Dev 83 1999 165 178
101. E.N. Meyers, M. Lewandoski, and G.R. Martin An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination Nat Genet 18 1998 136 141
102. J.S. Xu, Z.H. Liu, and D.M. Ornitz Temporal and spatial gradients of Fgf8 and Fgfl7 regulate proliferation and differentiation of midline cerebellar structures Development 127 2000 1833 1843
103. L. Chen, R. Adar, X. Yang, E.O. Monsonego, C. Li, and P.V. Hauschka Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis J Clin Invest 104 1999 1517 1525
104. L. Chen, C. Li, W. Qiao, X. Xu, and C. Deng A Ser(365)->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia Hum Mol Genet 10 2001 457 465
105. C. Li, L. Chen, T. Iwata, M. Kitagawa, X.Y. Fu, and C.X. Deng A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors Hum Mol Genet 8 1999 35 44
106. Y.C. Wang, M.K. Spatz, K. Kannan, H. Hayk, A. Avivi, and M. Gorivodsky A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3 Proc Natl Acad Sci USA 96 1999 4455 4460
107. L. Dailey, E. Laplantine, R. Priore, and C. Basilico A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation J Cell Biol 161 2003 1053 1066
108. J.E. Henderson, M.C. Naski, M.M. Aarts, D. Wang, L. Cheng, and D. Goltzman Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells J Bone Miner Res 15 2000 155 165
109. Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, A., Y. Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J Cell Sci 2002;115:553-62.
110. E. Minina, C. Kreschel, M.C. Naski, D.M. Ornitz, and A. Vortkamp Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation Dev Cell 3 2002 439 449
111. J.L. Ellsworth, J. Berry, T. Bukowski, J. Claus, A. Feldhaus, and S. Holderman Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors Osteoarthr Cartil 10 2002 308 320
112. H.Y. Lin, J.S. Xu, D.M. Ornitz, S. Halegoua, and M.J. Hayman The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC 12 cells by aFGF J Neurosci 16 1996 4579 4587
113. M.C. Naski, Q. Wang, J. Xu, and D.M. Ornitz Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia Nat Genet 13 1996 233 237
114. J.K. Wang, G. Gao, and M. Goldfarb Fibroblast growth factor receptors have different signaling and mitogenic potentials Mol Cell Biol 14 1994 181 188
115. Q. Wang, R.P. Green, G. Zhao, and D.M. Ornitz Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains Development 128 2001 3867 3876
116. S. Raffioni, D. Thomas, E.D. Foehr, L.M. Thompson, and R.A. Bradshaw Proc Natl Acad Sci USA Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC 12 cells 96 1999 7178 7183
117. A. Raucci, E. Laplantine, A. Mansukhani, and C. Basilico Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes J Biol Chem 279 2004 1747 1756
118. S. Murakami, G. Balmes, S. McKinney, Z. Zhang, D. Givol, and B. De Crombrugghe Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype Genes Dev 18 2004 290 305
119. K.C. Hart, S.C. Robertson, M.Y. Kanemitsu, A.N. Meyer, J.A. Tynan, and D.J. Donoghue Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4 Oncogene 19 2000 3309 3320
120. L. Legeai-Mallet, C. Benoist-Lasselin, A. Munnich, and J. Bonaventure Overexpression of FGFR3, Statl, Stat5 and p21Cipl correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias Bone 34 2004 26 36
121. M. Sahni, D.C. Ambrosetti, A. Mansukhani, R. Gertner, D. Levy, and C. Basilico FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway Genes Dev 13 1999 1361 1366
122. W.C.S. Su, M. Kitagawa, N.R. Xue, B. Xie, S. Garofalo, and J. Cho Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism Nature 386 1997 288 292
123. L. Legeai-Mallet, C. Benoist-Lasselin, A.L. Delezoide, A. Munnich, and J. Bonaventure Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia J Biol Chem 273 1998 13007 13014
124. M. Sahni, R. Raz, J.D. Coffin, D. Levy, and C. Basilico STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2 Development 128 2001 2119 2129
125. Y. Yamanaka, K. Ueda, Y. Seino, and H. Tanaka Molecular basis for the treatment of achondroplasia Horm Res 60 3 2003 60 64
126. V.P. Eswarakumar, E. Monsonego-Ornan, M. Pines, I. Antonopoulou, G.M. Morriss-Kay, and P. Lonai The IIIc alternative of Fgfr2 is a positive regulator of bone formation Development 129 2002 3783 3793
127. K. Yu, J. Xu, Z. Liu, D. Sosic, J. Shao, and E.N. Olson Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth Development 130 2003 3063 3074
128. G. Valverde-Franco, H. Liu, D. Davidson, S. Chai, H. Valderrama-Carvajal, and D. Goltzman Defective bone mineralization and osteopenia in young adult FGFR3-/- mice Hum Mol Genet 13 2004 271 284